This site is intended for health professionals only

Published on 6 July 2007

Share this story:
Twitter
LinkedIn

Rosuvastatin freed from black triangle

teaser

Following a comprehensive analysis of pre- and postmarketing data by the UK’s MHRA and Commission on Human Medicines, the risk-benefit profile for rosuvastatin (Crestor



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn